source
- Attovia Therapeutics and Braveheart Bio announce plans for biotech IPOs amid market upswingAttovia Therapeutics and Braveheart Bio disclosed on Tuesday that they intend to go public, joining a recent wave of large biotech offerings. Attovia, which was spun out of Alamar Biosciences in 2…
- Coronary artery disease deaths in US have halved since 1990, but most recent deaths remain preventableA new analysis published in JAMA Cardiology shows that deaths from ischemic heart disease in the United States dropped by more than half between 1990 and 2023. The decline is attributed to improved…